ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/20 | 1,565 | 1,581 | 1,562 | 1,570 | +13 | +0.8% | 39,300 |
| 2024/09/19 | 1,564 | 1,579 | 1,557 | 1,557 | ±0 | ±0% | 41,700 |
| 2024/09/18 | 1,566 | 1,573 | 1,550 | 1,557 | -10 | -0.6% | 17,100 |
| 2024/09/17 | 1,555 | 1,573 | 1,549 | 1,567 | +12 | +0.8% | 45,200 |
| 2024/09/13 | 1,597 | 1,597 | 1,555 | 1,555 | -29 | -1.8% | 29,700 |
| 2024/09/12 | 1,599 | 1,599 | 1,576 | 1,584 | +14 | +0.9% | 20,900 |
| 2024/09/11 | 1,608 | 1,623 | 1,556 | 1,570 | -36 | -2.2% | 54,400 |
| 2024/09/10 | 1,636 | 1,642 | 1,606 | 1,606 | -15 | -0.9% | 25,600 |
| 2024/09/09 | 1,579 | 1,631 | 1,579 | 1,621 | +3 | +0.2% | 37,900 |
| 2024/09/06 | 1,638 | 1,642 | 1,605 | 1,618 | -20 | -1.2% | 42,500 |
| 2024/09/05 | 1,580 | 1,669 | 1,575 | 1,638 | +57 | +3.6% | 123,800 |
| 2024/09/04 | 1,585 | 1,601 | 1,577 | 1,581 | -21 | -1.3% | 72,000 |
| 2024/09/03 | 1,590 | 1,605 | 1,586 | 1,602 | +8 | +0.5% | 44,000 |
| 2024/09/02 | 1,615 | 1,615 | 1,588 | 1,594 | -4 | -0.3% | 25,600 |
| 2024/08/30 | 1,602 | 1,609 | 1,595 | 1,598 | -5 | -0.3% | 34,400 |
| 2024/08/29 | 1,585 | 1,603 | 1,581 | 1,603 | +3 | +0.2% | 28,700 |
| 2024/08/28 | 1,600 | 1,602 | 1,585 | 1,600 | ±0 | ±0% | 40,700 |
| 2024/08/27 | 1,598 | 1,610 | 1,585 | 1,600 | +3 | +0.2% | 48,300 |
| 2024/08/26 | 1,626 | 1,626 | 1,579 | 1,597 | -20 | -1.2% | 77,000 |
| 2024/08/23 | 1,589 | 1,626 | 1,570 | 1,617 | +28 | +1.8% | 80,900 |
| 2024/08/22 | 1,578 | 1,589 | 1,570 | 1,589 | +13 | +0.8% | 36,500 |
| 2024/08/21 | 1,560 | 1,577 | 1,550 | 1,576 | +13 | +0.8% | 54,100 |
| 2024/08/20 | 1,563 | 1,577 | 1,548 | 1,563 | +21 | +1.4% | 60,000 |
| 2024/08/19 | 1,548 | 1,566 | 1,536 | 1,542 | -6 | -0.4% | 67,900 |
| 2024/08/16 | 1,565 | 1,567 | 1,537 | 1,548 | +12 | +0.8% | 67,500 |
| 2024/08/15 | 1,533 | 1,549 | 1,528 | 1,536 | +3 | +0.2% | 56,000 |
| 2024/08/14 | 1,528 | 1,555 | 1,520 | 1,533 | +19 | +1.3% | 84,600 |
| 2024/08/13 | 1,521 | 1,521 | 1,460 | 1,514 | -45 | -2.9% | 257,300 |
| 2024/08/09 | 1,610 | 1,674 | 1,492 | 1,559 | -40 | -2.5% | 300,800 |
| 2024/08/08 | 1,599 | 1,624 | 1,588 | 1,599 | +9 | +0.6% | 105,700 |
| 2024/08/07 | 1,590 | 1,629 | 1,572 | 1,590 | -17 | -1.1% | 118,300 |
| 2024/08/06 | 1,562 | 1,627 | 1,562 | 1,607 | +115 | +7.7% | 176,700 |
| 2024/08/05 | 1,546 | 1,572 | 1,466 | 1,492 | -88 | -5.6% | 411,000 |
| 2024/08/02 | 1,606 | 1,613 | 1,577 | 1,580 | -63 | -3.8% | 148,700 |
| 2024/08/01 | 1,701 | 1,701 | 1,639 | 1,643 | -81 | -4.7% | 125,500 |
| 2024/07/31 | 1,691 | 1,724 | 1,686 | 1,724 | +22 | +1.3% | 52,200 |
| 2024/07/30 | 1,715 | 1,715 | 1,690 | 1,702 | -8 | -0.5% | 56,200 |
| 2024/07/29 | 1,730 | 1,734 | 1,707 | 1,710 | -20 | -1.2% | 80,800 |
| 2024/07/26 | 1,750 | 1,757 | 1,719 | 1,730 | -5 | -0.3% | 68,600 |
| 2024/07/25 | 1,711 | 1,735 | 1,703 | 1,735 | +6 | +0.3% | 70,900 |
| 2024/07/24 | 1,796 | 1,796 | 1,728 | 1,729 | -76 | -4.2% | 165,600 |
| 2024/07/23 | 1,789 | 1,824 | 1,780 | 1,805 | +29 | +1.6% | 184,200 |
| 2024/07/22 | 1,784 | 1,799 | 1,758 | 1,776 | +2 | +0.1% | 175,300 |
| 2024/07/19 | 1,738 | 1,774 | 1,727 | 1,774 | +47 | +2.7% | 149,200 |
| 2024/07/18 | 1,708 | 1,771 | 1,708 | 1,727 | +13 | +0.8% | 177,500 |
| 2024/07/17 | 1,740 | 1,755 | 1,703 | 1,714 | -17 | -1% | 88,700 |
| 2024/07/16 | 1,718 | 1,739 | 1,715 | 1,731 | +29 | +1.7% | 152,500 |
| 2024/07/12 | 1,670 | 1,715 | 1,670 | 1,702 | +24 | +1.4% | 103,100 |
| 2024/07/11 | 1,686 | 1,687 | 1,660 | 1,678 | +4 | +0.2% | 38,100 |
| 2024/07/10 | 1,680 | 1,695 | 1,667 | 1,674 | -6 | -0.4% | 55,300 |
51～
100
件表示中 / 2191件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 156,900円 | -5.1% | -21.2% | 5.10% | 9.91倍 | 1.89倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ハートシード | 150,300円 | +154.1% | - | 0.00% | - | 7.37倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ダイト | 212,900円 | +4.5% | -10.8% | 3.29% | 14.15倍 | 0.63倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| 扶桑薬 | 255,500円 | +8.3% | +98.1% | 3.21% | 8.39倍 | 0.57倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| セルソース | 102,500円 | -3.0% | -55.9% | 0.49% | 48.70倍 | 3.36倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム
